Less Ads, More Data, More Tools Register for FREE

Pin to quick picks3i Group Regulatory News (III)

Share Price Information for 3i Group (III)

Share Price is delayed by 15 minutes
Get Live Data
2,704.00    46.00 (1.73%)
Bid:
2,697.00
Ask:
2,698.00
Spread: 1.00 (0.037%)
Market Cap: £27.19b
III Live PriceLast checked at - London Stock Exchange

Intraday 3i Group Share Chart

Directorate Change

24 Oct 2018 09:14

RNS Number : 0179F
3i Group PLC
24 October 2018
 

 

3i Group plc: non-executive Director appointment

 

Coline McConville

3i Group plc announces the appointment of Coline McConville as a non-executive Director with effect from 1 November 2018.

 

Coline McConville is currently a non-executive director of Fevertree Drinks plc, Inchcape plc and Travis Perkins plc. She is also a member of the Supervisory Board of Tui AG. She was previously a non-executive director of Tui Travel plc, UTV Media plc, Wembley National Stadium Limited, Shed Media plc and HBOS plc.

 

Prior to that Coline was Chief Operating Officer and Chief Executive Officer Europe of Clear Channel International Limited and had previously worked for McKinsey.

 

Simon Thompson, 3i Chairman, said: "We are very pleased to announce Coline's appointment to 3i's Board. She brings extensive commercial experience in a variety of sectors and significant board experience."

 

Coline McConville commented: "I am very pleased to be joining 3i as the firm continues to focus on successfully executing its strategic plan. 3i has a strong management team, a strong institutional franchise and is well placed to continue to generate value for its shareholders."

 

There are no further matters to be disclosed in accordance with paragraph 9.6.13R of the UKLA's Listing Rules.

 

 

-Ends-

 

For further information, contact:

Kathryn van der Kroft 020 7975 3021

Communications Director

 

Silvia Santoro 020 7975 3258

Investor Relations Director

 

Notes to Editors:

 

About 3i

 

3i is a leading international investment manager focused on mid-market private equity and infrastructure. Its core investment markets are northern Europe and North America. For further information, please visit: www.3i.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAMIBPTMBBTMBP
Date   Source Headline
4th Jan 20234:41 pmRNSDirector/PDMR Shareholding
3rd Jan 20239:25 amRNSPortfolio Update
30th Dec 20228:10 amRNSDirector Declaration
20th Dec 202210:54 amRNSHolding(s) in Company
19th Dec 20222:52 pmRNSHolding(s) in Company
9th Dec 202212:04 pmRNSBlock listing Interim Review
7th Dec 202212:09 pmRNSAdditional Listing
2nd Dec 202210:51 amRNSHolding(s) in Company
30th Nov 20224:15 pmRNSTotal Voting Rights
30th Nov 20224:09 pmRNSDirector/PDMR Shareholding
10th Nov 20229:02 amRNSDoc re. Half Yearly Report 2022
10th Nov 20227:00 amRNSResults for the six months to 30 September 2022
31st Oct 20224:14 pmRNSTotal Voting Rights
31st Oct 20224:14 pmRNSDirector/PDMR Shareholding
4th Oct 20221:08 pmRNSPortfolio Update
30th Sep 20224:08 pmRNSTotal Voting Rights
30th Sep 20224:00 pmRNSDirector/PDMR Shareholding
26th Sep 20227:00 amRNSUpdate on portfolio and Capital Markets Seminar
31st Aug 20224:07 pmRNSTotal Voting Rights
31st Aug 20224:05 pmRNSDirector/PDMR Shareholding
8th Aug 20222:14 pmRNSDirector/PDMR Shareholding
29th Jul 20225:58 pmRNSDirector/PDMR Shareholding
29th Jul 20225:35 pmRNSTotal Voting Rights
21st Jul 20227:00 amRNSFY2023 Q1 performance update
1st Jul 202211:14 amRNSSection 430 (2B) Companies Act 2006 Statement
1st Jul 202211:04 amRNSPortfolio Update
1st Jul 202210:29 amRNSDirector/PDMR Shareholding
1st Jul 202210:15 amRNSDirector/PDMR Shareholding
30th Jun 20224:27 pmRNSTotal Voting Rights
30th Jun 20222:48 pmRNSDirector/PDMR Shareholding
30th Jun 20222:37 pmRNSResult of AGM
30th Jun 20222:34 pmRNSDoc re. AGM Resolutions
30th Jun 20222:09 pmRNSDirector/PDMR Shareholding
30th Jun 20227:00 amRNSAGM and portfolio update
29th Jun 20223:26 pmRNSDirector/PDMR Shareholding
29th Jun 20222:47 pmRNSDirector/PDMR Shareholding
28th Jun 20224:24 pmRNSDirector/PDMR Shareholding
9th Jun 202212:25 pmRNSBlock listing Interim Review
8th Jun 20222:35 pmRNSDirector/PDMR Shareholding
1st Jun 20221:43 pmRNSDirector/PDMR Shareholding
1st Jun 202212:58 pmRNSDTR 6.3.5
31st May 20223:57 pmRNSTotal Voting Rights
31st May 20223:54 pmRNSDirector/PDMR Shareholding
30th May 20222:20 pmRNSDirector/PDMR Shareholding
26th May 202212:44 pmRNSDoc re. 2022 Notice of AGM
19th May 20221:37 pmRNSDoc re. 2022 Annual Report and Accounts
17th May 20223:19 pmRNSHolding(s) in Company
12th May 20228:50 amRNSDirectorate Change
12th May 20227:00 amRNSResults for the year to 31 March 2022
29th Apr 20222:56 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.